These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2234330)

  • 21. Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.
    Kawabata S; Yang W; Barth RF; Wu G; Huo T; Binns PJ; Riley KJ; Ongayi O; Gottumukkala V; Vicente MG
    J Neurooncol; 2011 Jun; 103(2):175-85. PubMed ID: 20848301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Boron neutron capture therapy at the crossroads: challenges and opportunities.
    Barth RF
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced survival in a rat glioma model following BNCT.
    Clendenon NR; Barth RF; Goodman JH; Staubus AE; Gordon WA; Moeschberger ML; Alam F; Soloway AH; Fairchild RG; Slatkin DN
    Strahlenther Onkol; 1989; 165(2-3):222-5. PubMed ID: 2494736
    [No Abstract]   [Full Text] [Related]  

  • 25. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.
    Yang W; Barth RF; Wu G; Huo T; Tjarks W; Ciesielski M; Fenstermaker RA; Ross BD; Wikstrand CJ; Riley KJ; Binns PJ
    J Neurooncol; 2009 Dec; 95(3):355-365. PubMed ID: 19588228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
    Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
    Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.
    Hiramatsu R; Kawabata S; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake S; Kuroiwa T; Hao E; Vicente MG
    J Pharm Sci; 2015 Mar; 104(3):962-70. PubMed ID: 25546823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
    Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
    J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
    J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boron neutron capture therapy for murine malignant gliomas.
    Saris SC; Solares GR; Wazer DE; Cano G; Kerley SE; Joyce MA; Adelman LS; Harling OK; Madoc-Jones H; Zamenhof RG
    Cancer Res; 1992 Sep; 52(17):4672-7. PubMed ID: 1511433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distributions of sulfhydryl borane monomer and dimer in rodents and monomer in humans: boron neutron capture therapy of melanoma and glioma in boronated rodents.
    Slatkin DN; Joel DD; Fairchild RG; Micca PL; Nawrocky MM; Laster BH; Coderre JA; Finkel GC; Poletti CE; Sweet WH
    Basic Life Sci; 1989; 50():179-91. PubMed ID: 2751607
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model.
    Ceberg CP; Brun A; Kahl SB; Koo MS; Persson BR; Salford LG
    J Neurosurg; 1995 Jul; 83(1):86-92. PubMed ID: 7782856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of boron-10 (10B) in cell cultures exposed to mercaptododecaborate (Na2H(11)10B12SH) used for the neutron capture therapy of brain tumors.
    Mares V; Baudysová M; Kvítek J; Hnatovicz V; Cervená J; Vacík J; Folbergrová J
    J Pharmacol Exp Ther; 1992 Aug; 262(2):818-22. PubMed ID: 1501124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell survival measurements in an argon, aluminium and sulphur filtered neutron beam: a comparison with 24 keV neutrons and relevance to boron neutron capture therapy.
    Mill AJ; Morgan GR; Newman SM
    Br J Radiol; 1994 Oct; 67(802):1008-16. PubMed ID: 8000825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of boron neutron capture therapy (BNCT) and the design and dosimetry of a high-intensity, 24 keV, neutron beam for BNCT research.
    Perks CA; Mill AJ; Constantine G; Harrison KG; Gibson JA
    Br J Radiol; 1988 Dec; 61(732):1115-26. PubMed ID: 3064858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate receptor-targeted novel boron compound for boron neutron capture therapy on F98 glioma-bearing rats.
    Kanemitsu T; Kawabata S; Fukumura M; Futamura G; Hiramatsu R; Nonoguchi N; Nakagawa F; Takata T; Tanaka H; Suzuki M; Masunaga SI; Ono K; Miyatake SI; Nakamura H; Kuroiwa T
    Radiat Environ Biophys; 2019 Mar; 58(1):59-67. PubMed ID: 30474719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy.
    Sun T; Li Y; Huang Y; Zhang Z; Yang W; Du Z; Zhou Y
    Oncotarget; 2016 Jul; 7(28):43095-43108. PubMed ID: 27191269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.